Discovery of novel N-acylsulfonamide analogs as potent and selective EP3 receptor antagonists

被引：23

作者：

Asada, Masaki ^{[1
]}

Obitsu, Tetsuo ^{[1
]}

Kinoshita, Atsushi ^{[1
]}

Nakai, Yoshihiko ^{[1
]}

Nagase, Toshihiko ^{[1
]}

Sugimoto, Isamu ^{[1
]}

Tanaka, Motoyuki ^{[1
]}

Takizawa, Hiroya ^{[1
]}

Yoshikawa, Ken ^{[1
]}

Sato, Kazutoyo ^{[1
]}

Narita, Masami ^{[1
]}

Ohuchida, Shuichi ^{[1
]}

Nakai, Hisao ^{[1
]}

Toda, Masaaki ^{[1
]}

机构：

[1] Ono Pharmaceut Co Ltd, Minase Res Inst, Osaka 6188585, Japan

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 08期

关键词：

Prostaglandin; EP3; receptor; Antagonist; N-Acylsulfonamide; N-Acyl (3,4-difluorobenzene)sulfonamide; PROSTANOID RECEPTOR; MICE LACKING; SUBTYPE; MYOMETRIUM;

D O I：

10.1016/j.bmcl.2010.02.034

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of novel N-acylsulfonamide analogs were synthesized and evaluated for their binding affinity and antagonist activity for the EP3 receptor subtype. Representative compounds were also evaluated for their inhibitory effect on PGE(2)-induced uterine contraction in pregnant rats. Among those tested, a series of N-acylbenzenesulfonamide analogs were found to be more potent than the corresponding carboxylic acid analogs in both the in vitro and in vivo evaluations. The structure activity relationships (SAR) are also discussed. (C) 2010 Published by Elsevier Ltd.

引用

页码：2639 / 2643

页数：5

共 50 条

[21] Discovery of a Novel Series of Pyridone-Based EP3 Antagonists for the Treatment of Type 2 Diabetes
Zhang, Xuqing
Zhu, Bin
Guo, Lili
Bakaj, Ivona
Rankin, Matthew
Ho, George
Kauffman, Jack
Lee, Seunghun P.
Norquay, Lisa
Macielag, Mark J.
ACS MEDICINAL CHEMISTRY LETTERS, 2021, 12 (03): : 451 - 458
[22] Development of an in vivo active, dual EP1 and EP3 selective antagonist based on a novel acyl sulfonamide bioisostere
Downey, Jason D.
Saleh, Sam A.
Bridges, Thomas M.
Morrison, Ryan D.
Daniels, J. Scott
Lindsley, Craig W.
Breyer, Richard M.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (01) : 37 - 41
[23] Optimization of physicochemical properties of pyridone-based EP3 receptor antagonists
Zhang, Xuqing
Zhu, Bin
Guo, Lili
Bakaj, Ivona
Rankin, Matthew
Ho, George
Kauffman, Jack
Lee, Seunghun P.
Norquay, Lisa
Macielag, Mark
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 47
[24] EP3 RECEPTOR ANTAGONISTS: POTENTIAL FOR IMPROVING SAFETY IN THE ANTIPLATELET THERAPY FIELD
Singh, J.
Kiselyov, A. S.
DRUGS OF THE FUTURE, 2010, 35 (01) : 21 - 31
[25] Discovery and characterization of a potent and selective EP4 receptor antagonist
Schiffler, Matthew A.
Chandrasekhar, Srinivasan
Fisher, Matthew J.
Harvey, Anita
Kuklish, Steven L.
Wang, Xu-Shan
Warshawsky, Alan M.
York, Jeremy S.
Yu, Xiao-Peng
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (16) : 3176 - 3178
[26] Discovery of Novel Potent and Selective Agonists at the Melanocortin-3 Receptor
Carotenuto, Alfonso
Merlino, Francesco
Cai, Minying
Brancaccio, Diego
Yousif, Ali Munaim
Novellino, Ettore
Hruby, Victor J.
Grieco, Paolo
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (24) : 9773 - 9778
[27] Discovery of novel biaryl heterocyclic EP1 receptor antagonists
Hall, A
Bit, RA
Brown, SH
Chaignot, HM
Chessell, IP
Coleman, T
Giblin, GMP
Hurst, DN
Kilford, IR
Lewell, XQ
Michel, AD
Mohamed, S
Naylor, A
Novelli, R
Skinner, L
Spalding, DJ
Tang, SP
Wilson, RJ
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (10) : 2666 - 2671
[28] Discovery of novel arylpyrazole series as potent and selective opioid receptor-like 1 (ORL1) antagonists
Kobayashi, Kensuke
Uchiyama, Minaho
Ito, Hirokatsu
Takahashi, Hirobumi
Yoshizumi, Takashi
Sakoh, Hiroki
Nagatomi, Yasushi
Asai, Masanori
Miyazoe, Hiroshi
Tsujita, Tomohiro
Hirayama, Mioko
Ozaki, Satoshi
Tani, Takeshi
Ishii, Yasuyuki
Ohta, Hisashi
Okamoto, Osamu
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (13) : 3627 - 3631
[29] TEI-3356, A HIGHLY SELECTIVE AGONIST FOR THE PROSTAGLANDIN EP3 RECEPTOR
NEGISHI, M
HARAZONO, A
SUGIMOTO, Y
HAZATO, A
KUROZUMI, S
ICHIKAWA, A
PROSTAGLANDINS, 1994, 48 (05): : 275 - 283
[30] Discovery of a novel series of nonacidic benzofuran EP1 receptor antagonists
Allan, Amanda C.
Billinton, Andy
Brown, Susan H.
Chowdhury, Anita
Eatherton, Andrew J.
Fieldhouse, Charlotte
Giblin, Gerard M. P.
Goldsmith, Paul
Hall, Adrian
Hurst, David N.
Naylor, Alan
Rawlings, D. Anthony
Sime, Mairi
Scoccitti, Tiziana
Theobald, Pamela J.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (14) : 4343 - 4348

← 1 2 3 4 5 →